Osteoporosis Fracture Clinical Trial
Official title:
Central South University
We evaluated fracture risk assessment tools (FRAXs) from different regions in Chinese postmenopausal women.
This cross-sectional study recruited 264 postmenopausal women aged ≥50 years in September 2017. Basic information, general condition, history of illness, family history, and clinical risk factors were evaluated via a questionnaire. All subjects underwent a bone mineral density examination of the femur and lumbar spine and thoracolumbar spinal X-ray. The 10-year major osteoporotic fracture (MOF) and hip fracture (HF) risks were calculated using FRAXs from mainland China, Hong Kong, Taiwan, and Asia-America. All data were analyzed using SPSS 17.0. Sensitivity, specificity, and likelihood ratio were used to compare the effectiveness of each FRAX. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06024148 -
Continuation of Anti-osteoporotic Treatment 1 Year After Initial Administration
|
||
Completed |
NCT03710889 -
Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption
|
Phase 3 | |
Recruiting |
NCT05058976 -
Romosozumab Use to Build Skeletal Integrity
|
Phase 4 | |
Completed |
NCT03798444 -
Height Loss, Kyphosis Indicators, Bone Mineral Density and Vertebral Fractures in Chinese Postmenopausal Women
|
||
Completed |
NCT05366621 -
Post-fracture Medication and Mortality
|
||
Not yet recruiting |
NCT04597931 -
Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density
|
Phase 4 | |
Completed |
NCT02483286 -
Osteoporosis and Fall Prevention With Multiple Interventions in the Metropolitan Area
|
N/A | |
Enrolling by invitation |
NCT03178799 -
Randomized Fracture Liaison Services
|
||
Completed |
NCT02803190 -
Osteoporosis and Fall Prevention and Posture Correction Interventions in the Metropolitan Area
|
N/A | |
Recruiting |
NCT03451305 -
Postrual Reduction With Pillow in Osteoporotic Vertebral Fracture
|
N/A | |
Recruiting |
NCT03811509 -
Breast Cancer Women on Aromatase Inhibitors Treatment
|
Phase 4 | |
Recruiting |
NCT06379243 -
Development and Validation of a Postoperative Re-fracture Risk Model for Osteoporotic Spinal Fractures
|
N/A |